CVE-2026-39351
Unrestricted Doctype Access in Frappe API Enables Data Exposure
Publication date: 2026-04-07
Last updated on: 2026-04-10
Assigner: GitHub, Inc.
Description
Description
CVSS Scores
EPSS Scores
| Probability: | |
| Percentile: |
Meta Information
Affected Vendors & Products
| Vendor | Product | Version / Range |
|---|---|---|
| frappe | frappe | to 15.104.0 (exc) |
| frappe | frappe | From 16.0.0 (inc) to 16.14.0 (exc) |
Helpful Resources
Exploitability
| CWE ID | Description |
|---|---|
| CWE-862 | The product does not perform an authorization check when an actor attempts to access a resource or perform an action. |
Attack-Flow Graph
AI Powered Q&A
How does this vulnerability affect compliance with common standards and regulations (like GDPR, HIPAA)?:
The vulnerability allows unauthorized access to Doctypes through the API, potentially leading to unauthorized data exposure or manipulation.
Such unauthorized access and potential data exposure could negatively impact compliance with data protection regulations like GDPR and HIPAA, which require strict controls on access to sensitive data.
Can you explain this vulnerability to me?
CVE-2026-39351 is a vulnerability in the Frappe web application framework that allows unrestricted access to Doctypes via an API exploit. This means that before versions 16.14.0 and 15.104.0, attackers could use the API to access Doctypes without proper authorization.
How can this vulnerability impact me? :
This vulnerability can lead to unauthorized data exposure or manipulation because attackers can access Doctypes through the API without restrictions. This could compromise sensitive information or allow malicious changes to data within the Frappe framework.
What immediate steps should I take to mitigate this vulnerability?
To mitigate this vulnerability, you should upgrade the frappe package to version 16.14.0 or later, or 15.104.0 or later, where the unrestricted Doctype access via API exploit has been patched.